Evaluation of a lipid peroxidation-dependent ferroptosis RNA panel expression as a potential noninvasive biomarker in patients with nonalcoholic steatohepatitis-associated hepatocellular carcinoma
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-025-11340-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Amr A El-Sayed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Science, Ain Shams University, P.O. box 11566, Abbassia, Cairo, Egypt. amr_abdelhamid@edu.asu.edu.eg. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, Non-alcoholic Fatty Liver Disease, Liver Neoplasms. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Mounir Armanious Research Center.
Abstract (Originalsprache)
BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a major cause of hepatocellular carcinoma (HCC) and is the fastest growing etiology of HCC worldwide. A sensitive non-invasive marker for the diagnosis, screening, or clinical monitoring of NASH-HCC, however, has yet to be established. METHODS AND RESULTS: We used reverse transcription quantitative real-time PCR (RT-qPCR) to evaluate the expression of a bioinformatically-retrieved RNA panel related to lipid peroxidation-dependent ferroptosis in 193 subjects. The area under the receiver operating characteristic (ROC) curve was calculated to assess its diagnostic performance in discriminating NASH-associated HCC in NASH cases. ROC analysis indicated that the selected ferroptosis-related RNAs had various diagnostic performances. GPX4 had great potential in distinguishing NASH-associated HCC from NASH (AUC (SE) = 0.999 (0.002), P < 0.0001), which was superior to alpha-fetoprotein (AFP) and the recently developed GALAD score. Additionally, for the first time, we proposed that miR-762 has a critical role in NASH-associated HCC which can add to the unique molecular pattern of this etiology. CONCLUSIONS: Our study indicates that this RNA panel has significant superiority with respect to the current biomarkers for NASH-HCC diagnosis, and it is promising for clinical application and as a therapeutic target after further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Science, Ain Shams University, P.O. box 11566, Abbassia, Cairo, Egypt. amr_abdelhamid@edu.asu.edu.eg.
- Biochemistry Laboratory, Chemistry Department, Faculty of Education, Ain Shams University, P.O. box 11341, Roxy, Cairo, Egypt. amr_abdelhamid@edu.asu.edu.eg.
- Biochemistry Laboratory, Chemistry Department, Faculty of Education, Ain Shams University, P.O. box 11341, Roxy, Cairo, Egypt.
- Biochemistry Department, Faculty of Science, Ain Shams University, P.O. box 11566, Abbassia, Cairo, Egypt. Marwa_hegazy@sci.asu.edu.eg.
- General Surgery Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Translational & Applied Science Hub (TASH), Medical Biochemistry and Molecular biology Department, Faculty of Medicine, Ain Shams University, P.O. box 11381, Abbassia, Cairo, Egypt.
Förderung
- Mounir Armanious Research Center
Zitieren
APA
El-Sayed, A. A., Nabeel, A. I., Hegazy, M. G. A., El Anwar, A., & Matboli, M. (2026). Evaluation of a lipid peroxidation-dependent ferroptosis RNA panel expression as a potential noninvasive biomarker in patients with nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11340-2
Vancouver
El-Sayed AA, Nabeel AI, Hegazy MGA, El Anwar A, Matboli M. Evaluation of a lipid peroxidation-dependent ferroptosis RNA panel expression as a potential noninvasive biomarker in patients with nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Molecular Biology Reports. 2026. doi:10.1007/s11033-025-11340-2
BibTeX
@article{ElSayed2026,
author = {El-Sayed, Amr A and Nabeel, Asmaa I and Hegazy, Marwa G A and El Anwar, Ali and Matboli, Marwa},
title = {Evaluation of a lipid peroxidation-dependent ferroptosis RNA panel expression as a potential noninvasive biomarker in patients with nonalcoholic steatohepatitis-associated hepatocellular carcinoma},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-025-11340-2}
}
EUVIMED